Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MPIGH-2 maternal probiotic gut health trial
PACTR202404797704972Phase 2Not yet recruiting
- Sponsor
- Tropical Gastroenterology & Nutrition Group
- Start
- Apr 2024
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of vancomycin in Environmental Enteropathy (EED), sponsored by Tropical Gastroenterology & Nutrition Group. Primary endpoint: Change in mean count of selected fecal pathogens at day 35. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
vancomycin
03
Conditions
Environmental Enteropathy (EED)
Beyond the preview
Go deeper on PACTR202404797704972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202404797704972.